218 related articles for article (PubMed ID: 32110228)
1. Paraneoplastic Limbic Encephalitis Associated with Anti-CV2/CRMP5 Antibodies Secondary to Thymoma in an Adolescent.
Ibrahim Ismail I; K John J; Ibrahim M; Al-Hashel JY
Case Rep Neurol; 2020; 12(1):50-55. PubMed ID: 32110228
[TBL] [Abstract][Full Text] [Related]
2. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC
J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
[TBL] [Abstract][Full Text] [Related]
3. An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes.
Wang S; Hou H; Tang Y; Zhang S; Wang G; Guo Z; Zhu L; Wu J
Neural Regen Res; 2023 Nov; 18(11):2357-2364. PubMed ID: 37282453
[TBL] [Abstract][Full Text] [Related]
4. Anti-CV2/Collapsin Response Mediator Protein 5 (CRMP5) Paraneoplastic Encephalitis Induced by Small Cell Lung Cancer.
Helgason VÞ; Qureshi PAAA; Bollineni VR; Þórarinsson BL; Arkink EB
Cureus; 2023 Jan; 15(1):e34323. PubMed ID: 36865958
[TBL] [Abstract][Full Text] [Related]
5. CV2/CRMP5-antibody-related Paraneoplastic Neurologic Syndrome Associated with Gastrointestinal Stromal Tumor.
Fukushima H; Shibuya T; Awatsu T; Kurosawa T; Haga K; Murakami T; Serizawa N; Mori A; Hojo M; Yao T; Hattori N; Nagahara A
Intern Med; 2022 May; 61(10):1497-1501. PubMed ID: 34670904
[TBL] [Abstract][Full Text] [Related]
6. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
Fu P; He L; Tang N; Nie Q; Li Z
J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic Cerebellar Degeneration with Anti-CV2/CRMP5 Antibodies in Ovarian Cancer: Case Report and Review of the Literature.
Juárez-Vignon Whaley JJ; Carrera-Muiños A; Hernandez-Gutierrez KG; Rodriguez-Cid JR; Otero-Cerdeira ME; Garcia-Montes V
Case Rep Oncol; 2021; 14(3):1799-1805. PubMed ID: 35111012
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic Syndrome Presenting Combined Central and Peripheral Demyelination Associated with Anti-CV2/CRMP5 and Anti-NF186 Antibodies: A Case Report.
Liu B; Zhou L; Zheng Y; Sun C; Lin J
Brain Sci; 2023 Feb; 13(3):. PubMed ID: 36979184
[TBL] [Abstract][Full Text] [Related]
9. Screening for anti-titin antibodies in patients with various paraneoplastic neurological syndromes.
Berger B; Stich O; Labeit S; Rauer S
J Neuroimmunol; 2016 Jun; 295-296():18-20. PubMed ID: 27235344
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of paraneoplastic neurological syndrome associated with thymoma].
Liu HS; Ren HT; Zhou LX; Li SQ; Peng B; Cui LY; Guan HZ
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(35):2770-2774. PubMed ID: 28954337
[No Abstract] [Full Text] [Related]
11. Mechanism, and treatment of anti-CV2/CRMP5 autoimmune pain.
Martin L; Stratton HJ; Gomez K; Le Duy D; Loya-Lopez S; Tang C; Calderon-Rivera A; Ran D; Nunna V; Bellampalli SS; François-Moutal L; Dumaire N; Salih L; Luo S; Porreca F; Ibrahim M; Rogemond V; Honnorat J; Khanna R; Moutal A
bioRxiv; 2024 May; ():. PubMed ID: 38766071
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic Choreoathetosis in a Patient with Small Cell Lung Carcinoma and Anti-CRMP5/CV2: A Case Report.
Aydin D; Somnier F; Lassen LH
Case Rep Neurol; 2016; 8(1):16-9. PubMed ID: 26889151
[TBL] [Abstract][Full Text] [Related]
13. Anti-CV2/CRMP5 antibody-positive paraneoplastic neurological syndromes with chronic intestinal pseudo-obstruction in a small-cell lung cancer patient: a case report and literature review.
Yan J; Chen Z; Liang Y; Yang H; Cao L; Zhou Y; Zhao Y; Zhang Y
J Int Med Res; 2020 Dec; 48(12):300060520974466. PubMed ID: 33305627
[TBL] [Abstract][Full Text] [Related]
14. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
15. Limbic encephalitis and related cortical syndromes.
Rubio-Agusti I; Salavert M; Bataller L
Curr Treat Options Neurol; 2013 Apr; 15(2):169-84. PubMed ID: 23250843
[TBL] [Abstract][Full Text] [Related]
16. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].
Rosencher L; Maisonobe T; Lavole A; Milleron B; Ferroir JP
Rev Neurol (Paris); 2012 Apr; 168(4):371-4. PubMed ID: 22387203
[TBL] [Abstract][Full Text] [Related]
17. Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes.
Grativvol RS; Cavalcante WCP; Castro LHM; Nitrini R; Simabukuro MM
Curr Oncol Rep; 2018 Nov; 20(11):92. PubMed ID: 30415318
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature.
Jarius S; Wandinger KP; Borowski K; Stoecker W; Wildemann B
Clin Neurol Neurosurg; 2012 May; 114(4):331-5. PubMed ID: 22138095
[TBL] [Abstract][Full Text] [Related]
19. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
[TBL] [Abstract][Full Text] [Related]
20. Parkinsonism and dysautonomia with anti-CV2/CRMP5 associated paraneoplastic neurological syndromes mimicking multiple system atrophy: a case report.
Song J; Zhang Y; Lang Y; Wang YH; Shao J; Cui L
BMC Neurol; 2021 Oct; 21(1):408. PubMed ID: 34702214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
